NEW YORK, June 26 (GenomeWeb News) - OncoMethylome Sciences has priced its initial public offering at €7.50 ($9.44) per share and will begin trading on the Eurolist exchange in Brussels and Amsterdam tomorrow, the company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
In Nature this week: a Danish reference genome, and more.